THE SCIENCE
Selank is a synthetic heptapeptide analogue of tuftsin with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Research has investigated Selank in relation to neurobiology, anxiety-related behavior, cognitive processes, neurotrophic signaling, and immune regulation. PubMed
MOLECULAR STRUCTURE
Selank is a seven-amino-acid peptide derived from the biological peptide tuftsin. Its structure has been investigated in experimental research examining interactions with neurotransmitter and peptide-regulatory systems.
GABAergic SIGNALING
Experimental research has investigated Selank's effects on GABAergic signaling. Studies have reported modulation of GABA receptor binding, suggesting that interactions with GABA-related pathways may contribute to some of the biological effects observed in experimental models.
ENKEPHALIN & NEUROPEPTIDE SIGNALING
Research has examined Selank in relation to enkephalin metabolism. Experimental work has reported inhibition of enzymes involved in enkephalin degradation, providing one proposed mechanism for Selank's effects on neuropeptide signaling. PubMed
NEUROTROPHIC & COGNITIVE RESEARCH
Selank has been investigated in relation to neurotrophic signaling, learning, memory, and cognitive processes. Experimental research has examined changes in neurotrophic and neurotransmitter-related pathways under specific study conditions.
IMMUNE & CYTOKINE SIGNALING
- Research has also investigated Selank in relation to immune and cytokine signaling. Experimental studies have reported changes in the expression of cytokines, chemokines, and their receptors, while human research has examined changes in cytokine-related responses under specific clinical conditions.
RESEARCH LIMITATIONS
The evidence base for Selank includes experimental research and some human clinical studies, but the literature is relatively limited and much of the mechanistic evidence comes from preclinical models. Findings should be interpreted according to the study population, formulation, experimental design, route of administration, and specific endpoints measured.